Quantcast
Home > Quotes > BPMX

BioPharmX Corporation. Common (BPMX) Quote & Summary Data

BPMX 
$0.2005
*  
0.0058
2.81%
Get BPMX Alerts
*Delayed - data as of Jul. 17, 2018  -  Find a broker to begin trading BPMX now
Exchange:AMEX
Industry: Health Care
Community Rating:
View:    BPMX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
1.5
Today's High / Low
$ 0.21 / $ 0.196
Share Volume
2,449,737
90 Day Avg. Daily Volume
6,724,729
Previous Close
$ 0.2063
52 Week High / Low
$ 0.4835 / $ 0.10
Market Cap
38,399,506
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-0

Intraday Chart

Shares Traded

Share Volume:
2,449,737
90 Day Avg. Daily Volume:
6,724,729

Trading Range

The current last sale of $0.2005 is 100.50% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.21 $ 0.4835
 Low: $ 0.196 $ 0.10

Company Description (as filed with the SEC)

We are a specialty pharmaceutical company focused on utilizing our proprietary drug delivery technologies to develop and commercialize novel prescription and over­the­counter, or OTC, products that address large markets in dermatology and women's health. Our objective is to develop products that treat health or age­related conditions that: (1) are not presently being addressed or treated or (2) are currently treated with drug therapies or drug delivery approaches that are sub­optimal.  ... More ...  

Risk Grade

Where does BPMX fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info